NCT00227227已完成不适用
Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 750 人开始时间: 2004年5月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 750
研究概览
简要总结
The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of ankylosing spondylitis
排除标准
- •Contraindications according SmPC
研究者
相似试验
已完成
不适用
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque PsoriasisPlaque PsoriasisNCT00227240Pfizer753
Unknown
2 期
Etanercept (Enbrel) in Ankylosing SpondylitisAnkylosing SpondylitisNCT01289743Charite University, Berlin, Germany24
已完成
不适用
Study Evaluating The Use Of Etanercept In Patients With Ankylosing SpondylitisAnkylosing SpondylitisNCT00544557Pfizer1,715
Unknown
2 期
Etanercept (Enbrel) in Undifferentiated SpondyloarthritisSpondyloarthritisNCT01289730Charite University, Berlin, Germany8
已完成
2 期
A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki DiseaseMucocutaneous Lymph Node SyndromeKawasaki DiseaseNCT00841789Michael Portman205